- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05539222
Food Vouchers and Educational Intervention on Promoting Healthy Eating in Vulnerable Groups.
The Effect of Food Vouchers and an Educational Intervention on Promoting Healthy Eating in Vulnerable Groups. A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zaragoza, Spain, 50830
- María Isabel Iguacel Azorín
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: The inclusion criteria established were children and adults between 3 and 80 years of age with at least one adult per family unit that could speak and understand Spanish, French, or English.
Exclusion Criteria: Adults with severe illness or cognitive impairment were excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Food voucher plus health and nutritional education
Intervention and control group individuals received 120 euros/month during 3 months in food vouchers to be spent in supermarkets (60 euros/month if under 12y) plus a 10-week nutrition education for the intervention group.
|
Intervention and control group individuals received 120 euros/month during 3 months in food vouchers to be spent in supermarkets (60 euros/month if under 12y) plus a 10-week nutrition education for the intervention group.
Family food purchases were assessed using electronically recorded supermarket-obtained transactions.
|
|
No Intervention: Food voucher
Intervention and control group individuals received 120 euros/month during 3 months in food vouchers to be spent in supermarkets (60 euros/month if under 12y) plus a 10-week nutrition education for the intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diet quality (using NOVA classification)
Time Frame: 3 months
|
For the analysis of the products purchased by the family unit, the NOVA food classification was used.
This classification groups products according to their degree of manufacture so that Group 1 are those products that are unprocessed or minimally processed; Group 2 are culinary processed products or food industry ingredients (oil, sugar, honey, salt, butter); Group 3 are products processed from Group 1 foods, such as canned vegetables, nuts with salt or fish preserved in oil or water; and Group 4 are ultra-processed products [23].
The rationale and details on each NOVA food group have been described elsewhere [24].
Two investigators classified each food item according to the NOVA classification criteria, and for some items with discrepant classification, they were resolved by discussion.
Non-food items (e.g.
cleaning products and other products that were purchased with the non-food voucher) were classified as "Others".
|
3 months
|
|
Adherence Mediterranean diet
Time Frame: 10-week
|
To determine the degree of adherence to the Mediterranean diet, a specific short questionnaire of fourteen items validated for the Spanish population and used by the Prevention with Mediterranean Diet (PREDIMED) group was used. To obtain the score, a value of +1 is assigned to each of the items with a positive connotation with re-spect to DM and -1 when the items have a negative connotation. In adults, from the sum of the values obtained in the 14 items, the degree of adherence is determined, establishing two levels, so that if the total score is greater than or equal to nine, it is a diet with a good level of adherence, and if the total sum is less than nine, the diet has a low level of adherence. In children, the questionnaire consist of 16 questions and two possible answer options (yes/no), with 12 positive and 4 negative questions. The levels of adherence to the Mediterranean diet were classified into three groups: poor (0-3), average (4-7) and good (8-12). |
10-week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: 10-week
|
Anthropometric data included body weight and height presented to the nearest 0.01 kg and 0.01 mm, respectively.
Body Mass Index (BMI) was also calculated as body weight in kilograms divided by body height in meters squared (kg/m2).
and categorized into underweight (if BMI<18.5),
normal weight (18.5-24.9),
overweight (25-29.9)
and obesity (30 or greater).
BMI for children and adolescents was converted to an age- and sex-specific z-score using the extended IOTF criteria.
To assess weight and body composition, the TANITA MC780SMA portable beam scale was used.
|
10-week
|
|
Height
Time Frame: 10-week
|
Anthropometric data included body weight and height presented to the nearest 0.01 kg and 0.01 mm, respectively.
Body Mass Index (BMI) was also calculated as body weight in kilograms divided by body height in meters squared (kg/m2).
and categorized into underweight (if BMI<18.5),
normal weight (18.5-24.9),
overweight (25-29.9)
and obesity (30 or greater).
BMI for children and adolescents was converted to an age- and sex-specific z-score using the extended IOTF criteria.
To assess weight and body composition, the TANITA MC780SMA portable beam scale was used.
|
10-week
|
|
Blood pressure
Time Frame: 10-week
|
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) in mmHg were measured with an automatic oscillometric device (OMRON M6).
All participants were asked to sit for at least 5 min before taken the measurement.
Two measurements were taken with a 2-minute interval plus a further measurement in case of a >5% difference in blood pressure between the first two readings.
The average of the two (or three) measurements was used for statistical analysis.
|
10-week
|
|
Uric acid
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
Blood urea nitrogen (BUN)
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
ALP (Alkaline phosphatase)
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
ALT (alanine transaminase)
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
AST (aspartate aminotransferase)
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
Gamma-glutamyl transferase (GGT)
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
Triglycerides
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
Total cholesterol (TC)
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
High-density lipoprotein cholesterol (HDL-C)
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
Low-density lipoprotein cholesterol (LDL-C)),
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
Fasting glucose
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
|
Glycated hemoglobin A1c (HbA1c)
Time Frame: 10-week
|
Blood samples were taken by a hematologist after 8 hours of fasting.
Blood sam-ples were obtained at 9 am at pre- and post-intervention.
Further, all participants were required to fast for 8 hours before extracting their blood sample.
Approximately 10 mL of blood was extracted from the median antecubital vein and stored in an EDTA tube.
The plasma was centrifuged for 15 minutes at 3,000 rpm at 4°C.
Thereafter, the samples were stored frozen for subsequent analysis.
All samples were measured directly by an automatic hematology analyzer.
The laboratory carries out quality control according to standard procedures.
|
10-week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PI20/541
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Economic Problems
-
Adam ThalerMedtronicCompletedEconomic ProblemsUnited States
-
Beijing Jishuitan HospitalNot yet recruitingSurgery | Lumbar Spine Degeneration | Economic ProblemsChina
-
International Care Ministries, PhilippinesActive, not recruitingHealth Behavior | Economic Problems | Values, SocialUganda
-
Boston CollegeChristian Alliance for Orphans; Helping Children Worldwide; Child Reintegration...CompletedEvaluation of a Family Strengthening Program Evaluation in Sierra Leone to Prevent Family SeparationParent-Child Relations | Parenting | Emotion Regulation | Economic ProblemsSierra Leone
-
World BankHarvard School of Public Health (HSPH)Active, not recruitingHealth Behavior | Health Status | Economic Problems | Healthcare UtilizationNigeria
-
University of AdelaideRoyal Adelaide HospitalRecruitingEconomic Problems | Post-Surgical ComplicationAustralia
-
University of California, Los AngelesActive, not recruitingQuality of Life | Development, Child | Economic ProblemsUnited States
-
University of UtahCompletedEconomic ProblemsUnited States
-
World BankAddis Ababa University; Ethiopian Medical Association; PSI EthiopiaActive, not recruitingStress, Psychological | Emotion Regulation | Social Psychology | Mental Stress | Economic ProblemsEthiopia
-
University of ChicagoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingInjury Traumatic | Economic Problems | Firearm InjuryUnited States
Clinical Trials on Food vouchers and education
-
State University of New York at BuffaloActive, not recruitingType 2 DiabetesUnited States
-
University of Paris 13Institut national de prevention et d'education pour la sante; Direction Générale... and other collaboratorsCompletedPrimary Prevention | Nutrition PolicyFrance
-
University of California, San FranciscoAmerican Gastroenterological Association; University of California, San Francisco...RecruitingFood Insecurity Among Children | MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseUnited States
-
University of Texas Southwestern Medical CenterCompletedCancer | Diet, Healthy | Nutrition, HealthyUnited States
-
University of PaviaRecruitingDiet, Healthy | Diet Habit | Eating Disorders | Physical Inactivity | Eating HabitItaly
-
Universidad Francisco de VitoriaDavid Varillas Delgado; María Cristina Martincrespo-Blanco; Saray Blanco-Abril; María Gema Cid-Expósito and other collaboratorsCompleted
-
University of PennsylvaniaCompleted
-
Rutgers, The State University of New JerseyCompletedEnvironmental Exposure | Food SelectionUnited States
-
Sansum Diabetes Research InstituteHass Avocado BoardTerminatedDiabetes Mellitus, Type 2 | Dietary HabitsUnited States
-
Boston Children's HospitalUniversity of South Florida; Indiana UniversityRecruitingDiabetes Mellitus, Type 1United States